Clinical Trials Logo

Clinical Trial Summary

1. The course of AVN between Initial diagnosis and total hip replacement (THA) is analysed. The impact of early interventions versus conservative therapy in AVN before THA will be evaluated.

2. The short and long term outcomes of AVN patients undergoing THA with respect to complications, reoperations and quality of life are investigated. Potential risk factors for adverse outcomes will be investigated.


Clinical Trial Description

The study is to describe the course of avascular necrosis (AVN) of the femoral head from initial diagnosis and to collect data on treatment options and the further course in these cases. The duration from initial diagnosis of AVN to joint replacement as total hip arthroplasty (THA) will be analysed and the course after joint replacement with potential short- and long-term complications will be evaluated.

The impact of THA after AVN on activities of daily living will be assessed by Euroquol 5 Dimensions (EQ-5D-5L) and Hip disability and Osteoarthritis Outcome Score (HOOS) questionnaires. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03753282
Study type Observational
Source University Hospital, Basel, Switzerland
Contact
Status Withdrawn
Phase
Start date January 30, 2019
Completion date March 5, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04731077 - Avenir Complete Post-Market Clinical Follow-Up Study N/A
Recruiting NCT05227924 - Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
Completed NCT01643655 - Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head N/A
Active, not recruiting NCT02662881 - Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE
Active, not recruiting NCT05186168 - Corin MiniHip and Trinity Cup Clinical Surveillance Study
Recruiting NCT02552069 - Tritanium® Study in Japan
Recruiting NCT05460715 - The Medacta Quadra-P Anteverted Study
Recruiting NCT02748408 - The Medacta International SMS Post-Marketing Surveillance Study
Not yet recruiting NCT06123481 - Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis N/A
Recruiting NCT02783274 - Actis Total Hip System 2 Year Follow-up N/A
Completed NCT03639532 - Ceramic-on-Ceramic Versus Ceramic-on-HXLPE THA Phase 4
Completed NCT02065167 - Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip Phase 2
Recruiting NCT05982054 - Bone Marrow Cells With Core Decompression for AVN Treatment N/A
Active, not recruiting NCT04997005 - The Medacta International AMIStem-P Post-Marketing Surveillance Study